Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee
暂无分享,去创建一个
M. Hochberg | N. Lane | T. McAlindon | A. Difrancesco | A. Gibofsky | C. Swearingen | Y. Yazici | C. Latterman | N. Skrepnik | J. Tambiah